v3.26.1
Condensed Consolidated and Combined Statements of Equity (Unaudited) - USD ($)
Total
Common Shares Outstanding
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Treasury Stock, Common
Balance as of beginning of period, shares at Dec. 31, 2024   78,000,000        
Balance as of beginning of period, value at Dec. 31, 2024 $ 650,000,000 $ 1,000,000 $ 1,647,000,000 $ 654,000,000 $ 17,000,000 $ (1,669,000,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 61,000,000     61,000,000    
Period change (13,000,000)       (13,000,000)  
Dividends $ (32,000,000)     (32,000,000)    
Repurchase of common stock (in shares) (1,000,000)          
Repurchase of common stock $ (76,000,000)         (76,000,000)
Net share settlement of incentive equity awards (22,000,000)   (22,000,000)      
Change in deferred compensation $ 10,000,000   10,000,000      
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures 1,000,000          
Other $ 1,000,000   (1,000,000)      
Ending balance, shares at Mar. 31, 2025   78,000,000        
Balance as of end of period, value at Mar. 31, 2025 579,000,000 $ 1,000,000 1,636,000,000 683,000,000 4,000,000 (1,745,000,000)
Balance as of beginning of period, shares at Dec. 31, 2024   78,000,000        
Balance as of beginning of period, value at Dec. 31, 2024 650,000,000 $ 1,000,000 1,647,000,000 654,000,000 17,000,000 (1,669,000,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 149,000,000          
Period change (14,000,000)          
Ending balance, shares at Jun. 30, 2025   77,000,000        
Balance as of end of period, value at Jun. 30, 2025 570,000,000 $ 1,000,000 1,651,000,000 738,000,000 2,000,000 (1,822,000,000)
Balance as of beginning of period, shares at Mar. 31, 2025   78,000,000        
Balance as of beginning of period, value at Mar. 31, 2025 579,000,000 $ 1,000,000 1,636,000,000 683,000,000 4,000,000 (1,745,000,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 87,000,000     87,000,000    
Period change (2,000,000)       (2,000,000)  
Dividends $ (32,000,000)     (32,000,000)    
Repurchase of common stock (in shares) (1,000,000)          
Repurchase of common stock $ (77,000,000)         (77,000,000)
Change in deferred compensation 9,000,000   9,000,000      
Other 1,000,000   (1,000,000)      
Ending balance, shares at Jun. 30, 2025   77,000,000        
Balance as of end of period, value at Jun. 30, 2025 570,000,000 $ 1,000,000 1,651,000,000 738,000,000 2,000,000 (1,822,000,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options 5,000,000   5,000,000      
Balance as of beginning of period, shares at Dec. 31, 2025   75,000,000        
Balance as of beginning of period, value at Dec. 31, 2025 468,000,000 $ 1,000,000 14,000,000 471,000,000 3,000,000 (21,000,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 61,000,000     61,000,000    
Period change 5,000,000       5,000,000  
Dividends $ (33,000,000)     (33,000,000)    
Repurchase of common stock (in shares) (1,000,000)          
Repurchase of common stock $ (51,000,000)         (51,000,000)
Net share settlement of incentive equity awards (17,000,000)   (17,000,000)      
Change in deferred compensation $ 10,000,000   10,000,000      
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures 1,000,000          
Other $ (1,000,000)     1,000,000    
Ending balance, shares at Mar. 31, 2026   75,000,000        
Balance as of end of period, value at Mar. 31, 2026 447,000,000 $ 1,000,000 12,000,000 498,000,000 8,000,000 (72,000,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options 5,000,000   5,000,000      
Balance as of beginning of period, shares at Dec. 31, 2025   75,000,000        
Balance as of beginning of period, value at Dec. 31, 2025 468,000,000 $ 1,000,000 14,000,000 471,000,000 3,000,000 (21,000,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 163,000,000          
Period change 11,000,000          
Ending balance, shares at Jun. 30, 2026   75,000,000        
Balance as of end of period, value at Jun. 30, 2026 480,000,000 $ 1,000,000 23,000,000 568,000,000 14,000,000 (126,000,000)
Balance as of beginning of period, shares at Mar. 31, 2026   75,000,000        
Balance as of beginning of period, value at Mar. 31, 2026 447,000,000 $ 1,000,000 12,000,000 498,000,000 8,000,000 (72,000,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 102,000,000     102,000,000    
Period change 6,000,000       6,000,000  
Dividends $ (33,000,000)     (33,000,000)    
Repurchase of common stock (in shares) 0          
Repurchase of common stock $ (54,000,000)         (54,000,000)
Change in deferred compensation 9,000,000   9,000,000      
Other 1,000,000   0 1,000,000    
Ending balance, shares at Jun. 30, 2026   75,000,000        
Balance as of end of period, value at Jun. 30, 2026 480,000,000 $ 1,000,000 23,000,000 $ 568,000,000 $ 14,000,000 $ (126,000,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options $ 2,000,000   $ 2,000,000